TY - JOUR
T1 - Lysosomal regulation of cholesterol homeostasis in tuberous sclerosis complex is mediated via NPC1 and LDL-R
AU - Filippakis, Harilaos
AU - Alesi, Nicola
AU - Ogorek, Barbara
AU - Nijmeh, Julie
AU - Khabibullin, Damir
AU - Gutierrez, Catherine
AU - Valvezan, Alexander J.
AU - Cunningham, James
AU - Priolo, Carmen
AU - Henske, Elizabeth P.
N1 - Publisher Copyright:
© Filippakis et al.
PY - 2017
Y1 - 2017
N2 - Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes in TSC2-deficient cells. This TSC2-dependent transcriptional signature is associated with increased accumulation and intracellular levels of both total cholesterol and cholesterol esters. Unexpectedly, engaging this CQ-induced cholesterol uptake pathway together with inhibition of de novo cholesterol synthesis allows survival of TSC2-deficient, but not TSC2-expressing cells. The underlying mechanism of TSC2-deficient cell survival is dependent on exogenous cholesterol uptake via LDL-R, and endosomal trafficking mediated by Vps34. Simultaneous inhibition of lysosomal and endosomal trafficking inhibits uptake of esterified cholesterol and cell growth in TSC2-deficient, but not TSC2-expressing cells, highlighting the TSC-dependent lysosome-mediated regulation of cholesterol homeostasis and pointing toward the translational potential of these pathways for the therapy of TSC.
AB - Tuberous sclerosis complex (TSC) is a multisystem disease associated with hyperactive mTORC1. The impact of TSC1/2 deficiency on lysosome-mediated processes is not fully understood. We report here that inhibition of lysosomal function using chloroquine (CQ) upregulates cholesterol homeostasis genes in TSC2-deficient cells. This TSC2-dependent transcriptional signature is associated with increased accumulation and intracellular levels of both total cholesterol and cholesterol esters. Unexpectedly, engaging this CQ-induced cholesterol uptake pathway together with inhibition of de novo cholesterol synthesis allows survival of TSC2-deficient, but not TSC2-expressing cells. The underlying mechanism of TSC2-deficient cell survival is dependent on exogenous cholesterol uptake via LDL-R, and endosomal trafficking mediated by Vps34. Simultaneous inhibition of lysosomal and endosomal trafficking inhibits uptake of esterified cholesterol and cell growth in TSC2-deficient, but not TSC2-expressing cells, highlighting the TSC-dependent lysosome-mediated regulation of cholesterol homeostasis and pointing toward the translational potential of these pathways for the therapy of TSC.
KW - Chloroquine
KW - Cholesterol
KW - Lysosome
KW - MTORC1
KW - TSC
UR - http://www.scopus.com/inward/record.url?scp=85020692896&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85020692896&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.17485
DO - 10.18632/oncotarget.17485
M3 - Article
C2 - 28498820
AN - SCOPUS:85020692896
SN - 1949-2553
VL - 8
SP - 38099
EP - 38112
JO - Oncotarget
JF - Oncotarget
IS - 24
ER -